ReviewCurrent atherosclerosis reports2022

PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid-Based Therapy Era.

Ioanna Gouni-Berthold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.